<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04563104</url>
  </required_header>
  <id_info>
    <org_study_id>R 49 / 2020</org_study_id>
    <nct_id>NCT04563104</nct_id>
  </id_info>
  <brief_title>Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia</brief_title>
  <official_title>Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventilator Associated pneumonia (VAP) is associated with longer ICU length of stay, prolonged&#xD;
      mechanical ventilation, and increased use of antimicrobials, health-care cost and mortality .&#xD;
      Acute respiratory infections (ARIs) comprise a large and heterogeneous group of infections,&#xD;
      including bacterial infections, viral infections, and infections of other etiologies. Early&#xD;
      initiation of adequate antibiotic therapy is the cornerstone in the treatment. However,&#xD;
      overuse of antibiotics and prolonged duration of antibiotic therapy in patients with&#xD;
      bacterial ARIs in the hospital and intensive care setting is associated with increased&#xD;
      resistance for common bacteria, high costs, and adverse drug reactions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Actual">September 1, 2021</completion_date>
  <primary_completion_date type="Actual">August 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>correlation between lung ultrasound and procalcitonin.</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <enrollment type="Actual">62</enrollment>
  <condition>Ventilator Associated Pneumonia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lung Ultrasound</intervention_name>
    <description>We will evaluate the role of lung ultrasound on the duration of antibiotics, we hypothesize that ultrasound imaging may have a role, will be correlated with, procalcitonin (PCT). The created database will help in establishing conclusion and recommendations that will help to improve the antibiotics duration and decrease the resistance.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients having ventilator associated pneumonia (VAP) with positive sputum culture. VAP was&#xD;
        considered if the onset occurred following intubation of the trachea for 48 h and the&#xD;
        infection was absent before starting mechanical ventilation . Diagnosis of pneumonia was&#xD;
        based on radiographic finding of pulmonary infiltrate; findings should be new and&#xD;
        progressive and at least should satisfy two clinical criteria of the following: body&#xD;
        temperature &gt;38°C or &lt;35.5°C; leukocyte count &gt; 12,000 cells/mm3 or &lt;4000 cells/mm3; and&#xD;
        clinical evidence of pneumonia, such as purulent secretions and a decrease in oxygenation.&#xD;
&#xD;
        Diagnosis of VAP was confirmed microbiologically by positive bronchial secretion cultures&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years old or greater&#xD;
&#xD;
          -  Ventilator associated pneumonia (VAP) with positive sputum culture.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  use of immunosuppressive agents except for steroids,&#xD;
&#xD;
          -  neutropenia (white blood cell count ≤1000/mL)&#xD;
&#xD;
          -  patients whose primary diagnosis was community acquired pneumonia and other source of&#xD;
             infection.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 9, 2020</study_first_submitted>
  <study_first_submitted_qc>September 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mona Ammar</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

